|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Oct 31, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Residential condominium units for sale | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Prepaid expenses and other assets, net | ||||||||||||||||||||
| Pension asset | ||||||||||||||||||||
| Investments in unconsolidated joint venture | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Deferred rents receivable | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Loans payable, net | ||||||||||||||||||||
| Corporate credit facility, net | ||||||||||||||||||||
| Secured line of credit | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Pension liability | ||||||||||||||||||||
| Losses in excess of investment in unconsolidated joint venture | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued professional fees | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' (DEFICIT) EQUITY | ||||||||||||||||||||
| Preferred Stock Value | ||||||||||||||||||||
| Blank Check Preferred Stock | ||||||||||||||||||||
| Preferred Stock | ||||||||||||||||||||
| Special stock, $0.01 par value; 1 share authorized, issued and outstanding at December 31, 2024, and December 31, 2023 | ||||||||||||||||||||
| Common stock, $0.01 par value; 79,999,997 shares authorized; 72,487,481 and 44,965,083 shares issued at December 31, 2024, and December 31, 2023, respectively; 65,314,726 and 38,199,386 shares outstanding at December 31, 2024, and December 31, 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock (6,540,522 and 6,397,875 shares at September 30, 2022 and December 31, 2021, respectively) | ||||||||||||||||||||
| Treasury stock (7,172,755 and 6,765,697 shares at December 31, 2024, and December 31, 2023, respectively) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders' equity (deficit) | ||||||||||||||||||||
Loading...
